Position in NVS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,197,810
+$45,770 QoQ
Shares Held
7,643
+1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#573
of 1,603 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ruggaard & Associates LLC holds $2,434,853 across 3 Drug Manufacturers - General names. NVS ranks #1 (49.2% of the industry book) .
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,197,810 | 7,643 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,152,040 | 7,542 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $1,052,637 | 7,635 | Shares | Sole | 2026-02-20 | |
| 2025-09-30 | $948,847 | 7,399 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $895,352 | 7,399 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $824,840 | 7,399 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $709,000 | 7,286 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $853,563 | 7,421 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $782,268 | 7,348 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $736,018 | 7,609 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $758,486 | 7,512 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $770,265 | 7,562 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $747,944 | 7,412 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $673,624 | 7,322 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||